PP2AC Level Determines Differential Programming of p38-TSC-mTOR Signaling and Therapeutic Response to p38-Targeted Therapy in Colorectal Cancer

The p38 MAP kinase is a promising cancer drug target but its therapeutic effect is not fully understood. Here we report that the response of colorectal cancer (CRC) to p38 inhibitors (p38i) is highly variable: while p38i induces regression of one subgroup of CRCs, it stimulates growth of another sub...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yanjie, Wang, Xiaowen, Qin, Xiaoyu, Wang, Xinxin, Liu, Feng, White, Eileen, Zheng, X.F. Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4703732/
https://www.ncbi.nlm.nih.gov/pubmed/26844273
http://dx.doi.org/10.1016/j.ebiom.2015.11.031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4703732/
https://www.ncbi.nlm.nih.gov/pubmed/26844273
http://dx.doi.org/10.1016/j.ebiom.2015.11.031

Ejemplares similares